Key result
Navitian microcatheter achieves ~95% crossing success in complex coronary lesions with no device failures.
Why the study?
Under European Medical Device Regulation, post-market clinical follow-up is required to confirm safety and performance, but evidence on coronary microcatheters remains limited.
Does the Navitian coronary microcatheter achieve successful lesion crossing and safety in adult patients undergoing complex PCI?
Observational (n=102)
Yes
Does the Navitian coronary microcatheter achieve successful lesion crossing and safety in adult patients undergoing complex PCI?
The Navitian coronary microcatheter demonstrated high crossing effectiveness (95.2%) and an excellent safety profile in real-world complex PCI procedures.
Provides real-world microcatheter data in complex PCI; leaves open need for randomized PMCF confirmation under MDR.
Introduction and objectives: Coronary microcatheters play a key role in contemporary percutaneous coronary intervention (PCI), particularly in complex anatomies such as chronic total coronary occlusions. Under the European Medical Device Regulation (MDR 2017/745), post-market clinical follow-up (PMCF) studies are required to confirm safety and performance. However, PMCF evidence on coronary microcatheters remains limited. Our primary endpoint was to assess device effectiveness, defined as successful lesion or occlusion crossing. Procedural effectiveness was defined as final Thrombolysis in Myocardial Infarction grade-3 flow with < 30% residual percent diameter stenosis. Device safety endpoints included the absence of device-related mechanical failures, including rupture, kinking, or complicated retrieval. Methods: This prospective, multicenter, multinational, observational PMCF study evaluated the safety and performance of a coronary microcatheter (Navitian, iVascular, Spain) used according to CE-marked indications. Adult patients in whom the use of the device was attempted, usually in combination with other devices, were consecutively included. Clinical outcomes were assessed during in-hospital stay up to discharge. Results: A total of 102 patients with 115 coronary lesions were included. Lesion complexity was high: 57.4% chronic total coronary occlusions, 87.8% were American Heart Association type B2/C lesions, and 47.0% had significant calcification. Device effectiveness for lesion or occlusion crossing, evaluable in successfully wired lesions, was 95.2%. Procedural success was achieved in 100% of cases in which the device crossed. No device-related safety failures were observed. None of the adverse clinical events observed (4.3%) were adjudicated to the microcatheter. Conclusions: In this prospective, multinational PMCF study, the Navitian coronary microcatheter demonstrated high effectiveness and an excellent device-related safety profile in a real-world complex PCI, supporting its continued use in routine complex PCIs. (Clinicaltrials.gov NCT05292118). Keywords: Microcatheter. Complex PCI. Real-world data. Effectiveness. Safety.
No takes yet. Share an insight, caveat, or question.
Prado et al. (2026) conducted an observational in Complex percutaneous coronary intervention (PCI) / Chronic total occlusion (CTO) (n=102). Navitian microcatheter was evaluated on Evaluable device crossing. The Navitian microcatheter achieved a 95.2% evaluable device crossing success rate in complex coronary lesions, with no device failures reported.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: